261 related articles for article (PubMed ID: 12888921)
1. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1.
Gagnon V; St-Germain ME; Parent S; Asselin E
Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921
[TBL] [Abstract][Full Text] [Related]
2. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
3. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
4. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
5. PTEN sensitizes epidermal growth factor-mediated proliferation in endometrial carcinoma cells.
Tang LL; Yokoyama Y; Wan X; Iwagaki S; Niwa K; Tamaya T
Oncol Rep; 2006 Apr; 15(4):855-9. PubMed ID: 16525671
[TBL] [Abstract][Full Text] [Related]
6. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells.
Lilja JF; Wu D; Reynolds RK; Lin J
Anticancer Res; 2001; 21(3B):1969-74. PubMed ID: 11497285
[TBL] [Abstract][Full Text] [Related]
7. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
8. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma.
Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N
Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338
[TBL] [Abstract][Full Text] [Related]
9. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
10. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L
Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
12. Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells.
Wang Q; Wang X; Hernandez A; Hellmich MR; Gatalica Z; Evers BM
J Biol Chem; 2002 Sep; 277(39):36602-10. PubMed ID: 12140294
[TBL] [Abstract][Full Text] [Related]
13. Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
Campbell RA; Bhat-Nakshatri P; Patel NM; Constantinidou D; Ali S; Nakshatri H
J Biol Chem; 2001 Mar; 276(13):9817-24. PubMed ID: 11139588
[TBL] [Abstract][Full Text] [Related]
14. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
[TBL] [Abstract][Full Text] [Related]
15. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
[TBL] [Abstract][Full Text] [Related]
16. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
Kandasamy K; Srivastava RK
Cancer Res; 2002 Sep; 62(17):4929-37. PubMed ID: 12208743
[TBL] [Abstract][Full Text] [Related]
17. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
Chen X; Thakkar H; Tyan F; Gim S; Robinson H; Lee C; Pandey SK; Nwokorie C; Onwudiwe N; Srivastava RK
Oncogene; 2001 Sep; 20(42):6073-83. PubMed ID: 11593415
[TBL] [Abstract][Full Text] [Related]
18. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
19. Growth and activation of PI-3K/PKB and Akt by stromal cell-derived factor 1alpha in endometrial carcinoma cells with expression of suppressor endoprotein PTEN.
Li XP; Zhao D; Gao M; Zhao C; Wang JL; Wei LH
Chin Med J (Engl); 2006 Mar; 119(5):378-83. PubMed ID: 16542580
[TBL] [Abstract][Full Text] [Related]
20. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line.
Lee S; Choi EJ; Jin C; Kim DH
Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
